Muse Cell Whitepapers & Publications | MuseCell Innovations®

MCI White Paper

Authentic Dezawa MuseCells®:
Why source, protocol, and science all matter.

By Joseph Purita, MD

“Authenticity is not a matter of terminology. It is a matter of biological identity, scientific rigor, and patient safety.”

The clinical case for Authentic Dezawa MuseCells® from one of the field's most-cited orthobiologic surgeons. Reads through mechanism, safety, delivery, and what distinguishes the licensed cell line from generic “Muse-like” claims sold under MuseCell Innovations®' patented manufacturing process.

Read the paper

Published: May 2026

MCI Scientific Brief

Pluripotent Without the Pain:
How Dezawa MuseCells® dodge tumor formation.

By MuseCell Innovations®

“Dezawa MuseCells® retain pluripotent-like function, but their biology is organized to keep growth tightly controlled.”

Why authentic Dezawa MuseCells® stay non-tumorigenic despite their pluripotent-like capacity — endogenous tissue origin, low telomerase and slow proliferation, intact DNA-damage and p53 checkpoints, and a let-7-dominant, LIN28-negative growth-control axis. With two mechanistic figures.

Read the paper

Published: June 2026

MCI White Paper

The Role of Dezawa MuseCells® in
Orthopedics and Longevity.

A Comprehensive Review

“Why an endogenous, non-tumorigenic pluripotent stem cell may be uniquely suited to musculoskeletal repair — and to extending healthy lifespan.”

Stress-endurance, S1P–S1PR2 homing, and immune privilege across cartilage, bone, tendon, and joint preservation — plus the anti-senescent, longevity mechanisms and the clinical-translation path for orthopedic regeneration. Fully cited to the primary literature.

Read the paper